2013
DOI: 10.4236/abb.2013.47101
|View full text |Cite
|
Sign up to set email alerts
|

Shared and discrete interacting partners of ELL1 and ELL2 by yeast two-hybrid assay

Abstract:

ELL2 (eleven-nineteen lysine-rich leukemia transcription elongation factor), a component of a larger complex with pTEFb (cyclin T and CDK9) and AF4, is up-regulated in plasma cells where it influences mRNA processing by increasing exon skipping and enhancing proximal poly (A) site use. ELL2 is needed to produce the secretory-specific Ig heavy chain mRNA while ELL1 mRNA does not change in abundance with B cell stages. To investigate the potential interaction… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
6
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 38 publications
1
6
0
Order By: Relevance
“…2e). ZNF622 played a role in 140 embryonic development by activating the DNA-bound MYBL2 transcription factor 141 (Arumemi, et al 2013). These absent six exons resulted in another spliced transcript 142 isoform, which can be validated using the RNA-seq data.…”
Section: Introductionmentioning
confidence: 99%
“…2e). ZNF622 played a role in 140 embryonic development by activating the DNA-bound MYBL2 transcription factor 141 (Arumemi, et al 2013). These absent six exons resulted in another spliced transcript 142 isoform, which can be validated using the RNA-seq data.…”
Section: Introductionmentioning
confidence: 99%
“…Two recent reports have identified proteins which interact with TESTIN and are able to modulate TP53 activity. Firstly, ELL2 is a binding partner for TESTIN 26 and ELL proteins can bind to the transactivation domain of TP53 and inhibit transactivation activity 27 . Secondly, Zyxin, a known binding partner of TESTIN 28 , has been reported to modulate the TP53/HIPK2 pathway by stabilising the HIPK2 protein, which phosphorylates Ser46 of TP53 and induces apoptosis 29 .…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, two recent reports implicate the TP53 pathway as a potential mediator of TESTIN activity. Firstly, Zyxin, a known binding partner of TESTIN, has been reported to modulate the HIPK2/TP53 pathway [ 37 ] and secondly, TESTIN was identified as a binding partner for ELL2 [ 50 ], and ELL2 is known to bind and inhibit the transactivational activity of TP53 [ 41 ]. Accordingly, we hypothesised that the observed anti-tumour activities of TESTIN re-expression in ALL cells may be due to interactions with TP53 protein and function.…”
Section: Discussionmentioning
confidence: 99%